Annals of Coloproctology


A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer: Kyung Ha Lee, Min Sang Song, Jun Boem Park, Jin Soo Kim, Dae Young Kang, Ji Yeon Kim; Ann Coloproctol. 2013;29(5):192-197. Published online October 31, 2013; DOI: https://doi.org/10.3393/ac.2013.29.5.192
Crossref 5; Full text PubReader Citation PDF


Oncologic Outcome after Cessation or Dose Reduction of Capecitabine in Patients with Colon Cancer: Jung-A Yun, Hee Cheol Kim, Hyun-Sook Son, Hyoung Ran Kim, Hae Ran Yun, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Ho-Kyung Chun; Ann Coloproctol. 2010;26(4):287-292. Published online August 31, 2010; DOI: https://doi.org/10.3393/jksc.2010.26.4.287
Crossref 5; Full text PubReader Citation PDF


Capecitabine-based Neoadjuvant Chemoradiation Therapy in Locally-advanced Rectal Cancer.: Choi, Hong Jo , Park, Ki Jae , Lee, Tae Moo , Ha, Sang Sik , Lee, Ho Young , Lee, Hyung Sik; Ann Coloproctol. 2010;26(2):137-144.; DOI: https://doi.org/10.3393/jksc.2010.26.2.137; PDF

Search